drugset

drugset / Trial / NCT00077935

Civamide in OA of the Knee(s)

NCT00077935 ↗

Phase 3 Completed 351 enrolled Winston Laboratories

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis (OA) of the Knee(s).

Timeline

Start: 2003-11
Primary completion: 2005-07
Completion: 2005-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zucapsaicin	Small molecule	0.075 %	Topical

Indications